|
ARMC10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.335400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.383600E-01 |
| Normal-vs-Stage2 |
7.454800E-01 |
| Normal-vs-Stage3 |
1.613610E-01 |
| Normal-vs-Stage4 |
6.119000E-01 |
| Stage1-vs-Stage2 |
6.099200E-01 |
| Stage1-vs-Stage3 |
4.572800E-01 |
| Stage1-vs-Stage4 |
7.552800E-01 |
| Stage2-vs-Stage3 |
3.308200E-01 |
| Stage2-vs-Stage4 |
8.678600E-01 |
| Stage3-vs-Stage4 |
4.206400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.418560E-01 |
| Normal-vs-AfricanAmerican |
9.460100E-02 |
| Normal-vs-Asian |
8.859600E-01 |
| Caucasian-vs-AfricanAmerican |
1.418210E-02 |
| Caucasian-vs-Asian |
1.319170E-01 |
| AfricanAmerican-vs-Asian |
7.256100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.178000E-02 |
| Normal-vs-Female |
5.217800E-01 |
| Male-vs-Female |
1.282550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.857200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.789400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.185600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.220000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.652800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.938230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.245170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.080000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.896100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.856000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.000000E-01 |
| Classical-VS-Follicular |
2.224000E-01 |
| Classical-VS-Other |
3.046200E-01 |
| Classical-VS-Normal |
7.099600E-01 |
| Tall-VS-Follicular |
6.609200E-01 |
| Tall-VS-Other |
4.729800E-01 |
| Tall-VS-Normal |
5.054600E-01 |
| Follicular-VS-Other |
7.221600E-01 |
| Follicular-VS-Normal |
2.688000E-01 |
| Other-VS-Normal |
3.132800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.443420E-01 |
| Normal-vs-N1 |
2.049200E-01 |
| N0-vs-N1 |
8.825200E-01 |
|
|
